Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pediatrix Medical (MD) FCF Margin (2016 - 2025)

Pediatrix Medical (MD) has disclosed FCF Margin for 17 consecutive years, with 24.84% as the latest value for Q4 2025.

  • On a quarterly basis, FCF Margin fell 131.0% to 24.84% in Q4 2025 year-over-year; TTM through Dec 2025 was 14.09%, a 439.0% increase, with the full-year FY2025 number at 14.09%, up 439.0% from a year prior.
  • FCF Margin was 24.84% for Q4 2025 at Pediatrix Medical, down from 27.41% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 28.29% in Q2 2025 to a low of 26.35% in Q1 2025.
  • A 5-year average of 8.74% and a median of 16.55% in 2023 define the central range for FCF Margin.
  • Biggest YoY gain for FCF Margin was 3202bps in 2021; the steepest drop was -4772bps in 2021.
  • Pediatrix Medical's FCF Margin stood at 21.67% in 2021, then increased by 19bps to 25.71% in 2022, then dropped by -29bps to 18.26% in 2023, then surged by 43bps to 26.15% in 2024, then dropped by -5bps to 24.84% in 2025.
  • Per Business Quant, the three most recent readings for MD's FCF Margin are 24.84% (Q4 2025), 27.41% (Q3 2025), and 28.29% (Q2 2025).